Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15‐month prospective, observational study

Abstract

Androgen deprivation therapy use does significantly increase the depressive scores and enhance the incidence of depression among PCa patients who received ADT. Smoking and alcohol consumption are associated with depressive symptoms among PCa patients receiving ADT.